John B. Harlow Jr. - Chief Commercial Officer at Esperion Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
ESPR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John B. Harlow Jr. since 10 Jan 2025

Holdings reported by John B. Harlow Jr. for Esperion Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 424,536 $1,566,537 $3.69 04 Dec 2025 Direct
Stock Option (right to buy) 380,000 04 Dec 2025 Direct Common Stock

Transactions reported by John B. Harlow Jr. for Esperion Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.